Upregulation of TCONS-00039830 and Smad2 and downregulation of miR-455-3p in the MASLD and MASLD + OSA groups were validated in vivo and in vitro. The gene discussed is SMAD2; the disease is metabolic dysfunction-associated steatotic liver disease.